Literature DB >> 8615506

A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.

K Nishina1, K Mikawa, N Maekawa, Y Takao, M Shiga, H Obara.   

Abstract

Acid aspiration syndrome of induction of anesthesia is a life-threatening complication whose severity is affected by both pH and volume of the aspirated gastric juice. We compared the effects of two proton pump inhibitors (PPIs), lansoprazole and omeprazole, and an H2 blocker, ranitidine, on gastric secretion in a prospective, randomized, double-blind fashion in 200 adult patients of ASA physical status I undergoing elective surgery. The patients were divided into eight groups (n = 25 each) according to their premedication. The patients received lansoprazole-lansoprazole (Group L-L), lansoprazole-placebo (Group L-P), placebo-lansoprazole (Group P-L), omeprazole-omeprazole (Group O-O), omeprazole-placebo (Group O-P), placebo-omeprazole (Group P-O), placebo-ranitidine (Group P-R), or placebo-placebo (Group P-P), as the first and second medications. The dose of the study drug was 30 mg for lansoprazole, 150 mg for ranitidine, and 80 mg for omeprazole. The first medication was administered orally at 9:00 PM on the night before surgery and the second at 5:30 AM in the morning on the day of the surgery. Each patient fasted overnight and took the drug with 20 mL of water. After tracheal intubation, gastric fluid was aspirated via an orogastric tube and the volume and pH of the aspirate were measured. The pH of the aspirated gastric fluid was higher in Groups P-R, L-L, P-L, O-O, and O-P than in Group P-P (P < 0.05). The volume of the gastric contents was similar in Groups P-0 and P-P, and the other groups had smaller gastric volume than Group P-P (P < 0.05). Gastric fluid from patients in Group P-R was the least acidic (pH 6.1 +/- 1.2) and had the least volume (0.09 +/- 0.06 mL/kg). Group L-L was comparable with Group P-R in both pH and volume, whereas Groups P-L and O-O were similar to Group P-R only in volume. The proportion of patients at risk according to the traditional criteria (pH < 2.5 and volume 0.4 mL/kg) was significantly lower in Groups L-L (0%), P-L (4%), O-O (4%), and P-R (0%) than in Group P-P (48%) (P < 0.05). We concluded that two consecutive doses of lansoprazole or a morning dose of ranitidine seemed to be the most effective preanesthetic medication for reducing gastric acidity and volume.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615506     DOI: 10.1097/00000539-199604000-00027

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.

Authors:  H D Langtry; M I Wilde
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 2.  Effects of proton pump inhibitors on gastric emptying: a systematic review.

Authors:  Masaki Sanaka; Takatsugu Yamamoto; Yasushi Kuyama
Journal:  Dig Dis Sci       Date:  2009-12-10       Impact factor: 3.199

3.  Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients.

Authors:  Gretchen M Brophy; Marcia L Brackbill; Katherine L Bidwell; Donald F Brophy
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

4.  Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?

Authors:  K Clark; L Lam; D Currow
Journal:  Support Care Cancer       Date:  2009-03-17       Impact factor: 3.603

5.  Effect of pantoprazole and its interactions with vecuronium on the neuromuscular junction.

Authors:  Tejas K Patel; Parvati B Patel; C B Tripathi
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

6.  Effect of preoperative intravenous pantoprazole in elective-surgery patients: a pilot study.

Authors:  Joseph R Pisegna; Robyn G Karlstadt; Jeffrey A Norton; Ronald Fogel; David S Oh; G Jay Graepel; Mary Beth Dorr
Journal:  Dig Dis Sci       Date:  2008-08-27       Impact factor: 3.199

Review 7.  Switching between intravenous and oral pantoprazole.

Authors:  J R Pisegna
Journal:  J Clin Gastroenterol       Date:  2001-01       Impact factor: 3.062

8.  Evaluating ranitidine, pantoprazole and placebo on gastric pH in elective surgery.

Authors:  Tapas Bhattacharyya; Debabrata Sarbapalli; Ranabir Pal; Ujjal Sarkar; Sumit Kar; Kanak Kanti Kundu; Forhad Akhtar Zaman
Journal:  Saudi J Anaesth       Date:  2011-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.